Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness

Domaine:

healthcare

Type de record:

paper

Créateur:

RonAshPauAmy

Éditeur:

Roy

Hôte:

African sleeping sickness is a potentially fatal neglected disease affecting sub-Saharan Africa.

Visit

Licenses

http://rsc.li/journals-terms-of-use

Similaires

Molecular epidemiology of African sleeping sicknessModelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sicknessHistory of Sleeping Sickness in East AfricaScreening Strategies for a Sustainable Endpoint for Gambiense Sleeping SicknessNovel lead compounds in pre-clinical development against African sleeping sicknessCell Cycle Inhibition To Treat Sleeping Sickness

Molecular epidemiology of African sleeping sickness

SUMMARY Human sleeping sickness in Africa, caused by Trypanosoma brucei spp. raises a number of q

Modelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sickness

Abstract Gambiense human African trypanosom

History of Sleeping Sickness in East Africa

SUMMARY The history of human sleeping sickness in East Africa is characterized by the appearance of

Screening Strategies for a Sustainable Endpoint for Gambiense Sleeping Sickness

Abstract Background Gambiense human African

Novel lead compounds in pre-clinical development against African sleeping sickness

This article reviews the recent progress in drug development against the African sleeping sickness.

Cell Cycle Inhibition To Treat Sleeping Sickness

ABSTRACT African trypanosomiasis is caused by infection with the protozoan parasite Trypanosoma bru